These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9444569)

  • 1. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.
    Jiménez-Jiménez FJ; de Bustos F; Molina JA; Benito-León J; Tallón-Barranco A; Gasalla T; Ortí-Pareja M; Guillamón F; Rubio JC; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1997; 104(6-7):703-10. PubMed ID: 9444569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis.
    de Bustos F; Jiménez-Jiménez FJ; Molina JA; Esteban J; Guerrero-Sola A; Zurdo M; Ortí-Pareja M; Tallón-Barranco A; Gómez-Escalonilla C; Ramírez-Ramos C; Arenas J; Enríquez de Salamanca R
    J Neural Transm (Vienna); 1998; 105(6-7):703-8. PubMed ID: 9826112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease.
    Meseguer I; Molina JA; Jiménez-Jiménez FJ; Aguilar MV; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Ortí-Pareja M; Zurdo M; Berbel A; Barrios E; Martínez-Para MC
    J Neural Transm (Vienna); 1999; 106(3-4):309-15. PubMed ID: 10392539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease.
    Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R
    J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis.
    Jiménez-Jiménez FJ; de Bustos F; Molina JA; de Andrés C; Gasalla T; Ortí-Pareja M; Zurdo M; Porta J; Castellano-Millán F; Arenas J; Enríquez de Salamanca R
    Neurosci Lett; 1998 Jun; 249(1):65-7. PubMed ID: 9672390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease.
    Molina JA; Jiménez-Jiménez FJ; Aguilar MV; Meseguer I; Mateos-Vega CJ; González-Muñoz MJ; de Bustos F; Porta J; Ortí-Pareja M; Zurdo M; Barrios E; Martínez-Para MC
    J Neural Transm (Vienna); 1998; 105(4-5):479-88. PubMed ID: 9720975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lipoprotein oxidation in Alzheimer's disease.
    Schippling S; Kontush A; Arlt S; Buhmann C; Stürenburg HJ; Mann U; Müller-Thomsen T; Beisiegel U
    Free Radic Biol Med; 2000 Feb; 28(3):351-60. PubMed ID: 10699746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease.
    Kontush A; Mann U; Arlt S; Ujeyl A; Lührs C; Müller-Thomsen T; Beisiegel U
    Free Radic Biol Med; 2001 Aug; 31(3):345-54. PubMed ID: 11461772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease.
    Rubio JC; de Bustos F; Molina JA; Jiménez-Jiménez FJ; Benito-León J; Martín MA; Campos Y; Ortí-Pareja M; Cabrera-Valdivia F; Arenas J
    J Neurol Sci; 1998 Mar; 155(2):192-5. PubMed ID: 9562266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease.
    Jiménez-Jiménez FJ; Molina JA; de Bustos F; Ortí-Pareja M; Benito-León J; Tallón-Barranco A; Gasalla T; Porta J; Arenas J
    Eur J Neurol; 1999 Jul; 6(4):495-7. PubMed ID: 10362906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease.
    Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J
    Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease.
    Molina JA; Jiménez-Jiménez FJ; Vargas C; Gómez P; de Bustos F; Gómez-Escalonilla C; Zurdo M; Tallón A; Martínez-Salio A; Porta-Etessam J; Villanueva C; Arenas J
    Acta Neurol Scand; 2002 Dec; 106(6):347-50. PubMed ID: 12460139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease.
    Molina JA; Jiménez-Jiménez FJ; Hernánz A; Fernández-Vivancos E; Medina S; de Bustos F; Gómez-Escalonilla C; Sayed Y
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1035-44. PubMed ID: 12111441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.
    Mangialasche F; Kivipelto M; Mecocci P; Rizzuto D; Palmer K; Winblad B; Fratiglioni L
    J Alzheimers Dis; 2010; 20(4):1029-37. PubMed ID: 20413888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
    Costa M; Horrillo R; Ortiz AM; Pérez A; Mestre A; Ruiz A; Boada M; Grancha S
    J Alzheimers Dis; 2018; 63(4):1395-1404. PubMed ID: 29782326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E and Alzheimer's disease: the mediating role of cellular aging.
    Casati M; Boccardi V; Ferri E; Bertagnoli L; Bastiani P; Ciccone S; Mansi M; Scamosci M; Rossi PD; Mecocci P; Arosio B
    Aging Clin Exp Res; 2020 Mar; 32(3):459-464. PubMed ID: 31054115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia.
    Laske C; Stransky E; Fritsche A; Eschweiler GW; Leyhe T
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):80-5. PubMed ID: 18806919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls.
    Laske C; Stransky E; Leyhe T; Eschweiler GW; Maetzler W; Wittorf A; Soekadar S; Richartz E; Koehler N; Bartels M; Buchkremer G; Schott K
    J Psychiatr Res; 2007 Aug; 41(5):387-94. PubMed ID: 16554070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.